SERPINE1 and myeloid sarcoma: Although there was no significant difference between MS patients and HCs for most of the tested mutations, a statistically significant difference was revealed in the genotype frequencies between MS patients and HCs for the FXIIIVal34Leu and PAI-1 4G/5G polymorphisms, as indicated in Table 3 and Table 4, respectively.